BICO Group AB (publ)

Stockholm Stock Exchange:BICO.ST

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🖨 3D Printing

🔬 Chemicals & Advanced Materials

🩺 Medical Instruments

Location

Sweden

Market Cap

USD 247.24 M

Share Price

USD 3.50

Avg Daily Volume

180,506

Change (1 day)

-3.27%

Change (1 year)

-17.03%

Change (YTD)

21.16%

BICO Group AB (publ) Share Price Year-To-Date (YTD) return on June 19, 2025: 21.16%

BICO Group AB (publ) Share Price Year-To-Date (YTD) return is 21.16% on June 19, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.

BICO Group AB (publ) 52-week low Share Price is USD 5.51 on June 19, 2025, which is 57.18% above the current Share Price.
BICO Group AB (publ) 52-week low Share Price is USD 2.54 on June 19, 2025, which is -27.50% below the current Share Price.
BICO Group AB (publ) average Share Price for the last 52 weeks is USD 3.65.

Daily

From:

To:

Zoom:

Key data

Date	Share Price Year-To-Date (YTD) return	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)

Stockholm Stock Exchange: BICO.ST

BICO Group AB (publ)

CEO	Ms. Maria Forss
IPO Date	Nov. 3, 2016
Location	Sweden
Headquarters	Arvid Wallgrens Backe 20
Employees	695
Sector	🏥 Health Care
Industries Biotechnology 🖨 3D Printing 🔬 Chemicals & Advanced Materials 🩺 Medical Instruments

Description

BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues for applications in regulatory testing. This segment also offers services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharmaceutical and biotechnology companies. The Bioautomation segment offers products in precision dispensing and biosensor technology to the industrial customer; and diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. In addition, it offers core industrial ecosystem, tissue engineering, multi-omics, cell line development, and diagnostics solutions. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was founded in 2016 and is based in Gothenburg, Sweden.